President & CEO, The Joint Commission
Health Evolution Leadership Committee

Jonathan B. Perlin, M.D., Ph.D., M.S.H.A., M.A.C.P., F.A.C.M.I. became the seventh President and CEO of The Joint Commission Enterprise on March 1, 2022. Previously, as President, Clinical Operations and Chief Medical Officer, HCA Healthcare, Dr. Perlin led clinicians, data scientists and researchers in developing a learning health system model for improving care at the system’s 189 hospitals and 2,200 other locations. His team’s work achieved national recognition for preventing elective pre-term deliveries, reducing maternal mortality, using AI to improve sepsis survival, and developing public-private-academic partnerships for improving infection prevention and treating COVID. Dr. Perlin’s CHARGE consortium partnered HCA, AHRQ and academia and created a reusable platform for accelerated research using real-world evidence from the care of over 400,000 COVID inpatients.

Before HCA, Dr. Perlin was Under Secretary for Health in the U.S. Department of Veterans Affairs, where he led the Veterans Health Administration to national prominence for clinical performance. He is a Congressional Budget Office Health Advisor, immediate past chair of the National Quality Forum and the VA Special Medical Advisory Group, and former MedPAC Commissioner. An elected member of the National Academy of Medicine, he has co-chaired Academy action collaboratives on digital health, combatting opioids and climate change.

Dr. Perlin’s board service includes Columbia University’s Health Policy and Management program, Vanderbilt University’s School of Engineering, and he served as a Trustee of Meharry Medical College for 15 years. Perennially recognized as one of the most influential leaders in healthcare, Dr. Perlin maintains faculty appointments at Vanderbilt University as Clinical Professor of Medicine and Health Policy, and at Virginia Commonwealth University as Adjunct Professor of Health Administration.